5-HT1A gene promoter polymorphism and [18F]MPPF binding potential in healthy subjects: A PET study

Behavioral and Brain Functions

Volumn 6, Issue , 2010, Pages

  Lothe, Amélie ^a,b   Boni, Claudette ^c   Costes, Nicolas ^d   Bouvard, Sandrine ^a   Gorwood, Philip ^c   Lavenne, Franck ^d   Alvarez, Marion ^d   Ryvlin, Philippe ^a,b,e  

^a CTRS IDEE   (France)

^b UNIVERSITÉ LYON 1   (France)

^c INSERM   (France)

^d CERMEP IMAGERIE DU VIVANT   (France)

^e HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2' METHOXYPHENYL) 1 [2' (N 2 PYRIDINYL) 4 FLUOROBENZAMIDO]ETHYL PIPERAZINE; FLUORINE 18; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG; 4 (2' METHOXYPHENYL) 1 (2' (N 2' PYRIDINYL) P (18F)FLUOROBENZAMIDO )ETHYLPIPERAZINE; 4-(2'-METHOXYPHENYL)-1-(2'-(N-2'-PYRIDINYL)-P-(18F)FLUOROBENZAMIDO )ETHYLPIPERAZINE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN ANTAGONIST; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN;

ALLELE; ARTICLE; BRAIN MAPPING; DNA POLYMORPHISM; FEMALE; FRONTAL CORTEX; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROMOTER REGION; RAPHE NUCLEUS; TEMPORAL CORTEX; ADULT; BRAIN; DNA SEQUENCE; DRUG ANTAGONISM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HEALTH STATUS; METABOLISM; PROTEIN BINDING; SCINTISCANNING; SEXUAL DEVELOPMENT;

ADULT; BRAIN; BRAIN MAPPING; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HEALTH STATUS; HOMOZYGOTE; HUMANS; MALE; PIPERAZINES; POLYMORPHISM, GENETIC; POSITRON-EMISSION TOMOGRAPHY; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PYRIDINES; RAPHE NUCLEI; RECEPTOR, SEROTONIN, 5-HT1A; SEQUENCE ANALYSIS, DNA; SEROTONIN ANTAGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX CHARACTERISTICS;

EID: 77954302325     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-6-37     Document Type: Article

References (36)

1. David SP, Murthy NV, Rabiner EA, Munafó MR, Johnstone EC, Jacob R, Walton RT, Grasby PM. A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci 2005, 25:2586-90. 10.1523/JNEUROSCI.3769-04.2005, 1942077, 15758168.
2. Lee M, Bailer UF, Frank GK, Henry SE, Meltzer CC, Price JC, Mathis CA, Putnam KT, Ferrell RE, Hariri AR, Kaye WH. Relationship of a 5-HT transporter functional polymorphism to 5-HT1A receptor binding in healthy women. Mol Psychiatry 2005, 10:715-6. 10.1038/sj.mp.4001680, 15940302.
3. Lothe A, Boni C, Costes N, Gorwood P, Bouvard S, Le Bars D, Lavenne F, Ryvlin P. Association between triallelic polymorphism of the serotonin transporter and [18F]MPPF binding potential at 5-HT1A receptors in healthy subjects. Neuroimage 2009, 47:482-92. 10.1016/j.neuroimage.2009.04.067, 19409499.
4. Zhuang ZP, Kung MP, Chumpradit S, Mu M, Kung HF. Derivatives of 4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl-p-iodobenzamido)ethyl]pipera zine (p-MPPI) as 5-HT1A ligands. J Med Chem 1994, 37:4572-5. 10.1021/jm00052a018, 7799409.
5. Van Wijngaarden I, Tulp MT, Soudijn W. The concept of selectivity in 5-HT receptor research. Eur J Pharmacol 1990, 188:301-12. 10.1016/0922-4106(90)90190-9, 2164935.
6. Zimmer L, Mauger G, Le Bars D, Bonmarchand G, Luxen A, Pujol JF. Effect of endogenous serotonin on the binding of the 5-hT1A PET ligand 18F-MPPF in the rat hippocampus: kinetic beta measurements combined with microdialysis. J Neurochem 2002, 80:278-86. 10.1046/j.0022-3042.2001.00696.x, 11902118.
7. Rbah L, Leviel V, Zimmer L. Displacement of the PET ligand 18F-MPPF by the electrically evoked serotonin release in the rat hippocampus. Synapse 2003, 49:239-45. 10.1002/syn.10235, 12827643.
8. Zimmer L, Riad M, Rbah L, Belkacem-Kahlouli A, Le Bars D, Renaud B, Descarries L. Toward brain imaging of serotonin 5-HT1A autoreceptor internalization. Neuroimage 2004, 22:1421-6. 10.1016/j.neuroimage.2004.03.020, 15219613.
9. Wu S, Comings DE. A common C-1018G polymorphism in the human 5-HT1A receptor gene. Psychiatr Genet 1999, 9:105-6. 10.1097/00041444-199906000-00010, 10412191.
10. Albert PR, Lemonde S. 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist 2004, 10:575-93. 10.1177/1073858404267382, 15534042.
11. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, Sequeira A, Kushwaha N, Morris SJ, Basak A, Ou XM, Albert PR. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 2003, 23:8788-99.
12. Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, Van Heertum RL, Arango V, Mann JJ. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 2006, 59:106-13. 10.1016/j.biopsych.2005.06.016, 16154547.
13. Sullivan GM, Ogden RT, Oquendo MA, Kumar JS, Simpson N, Huang YY, Mann JJ, Parsey RV. Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression. Biol Psychiatry 2009, 66:223-30. 10.1016/j.biopsych.2009.01.028, 19278673.
14. Hong CJ, Chen TJ, Yu YW, Tsai SJ. Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J 2006, 6:27-33. 10.1038/sj.tpj.6500340, 16302021.
15. Costes N, Merlet I, Ostrowsky K, Faillenot I, Lavenne F, Zimmer L, Ryvlin P, Le Bars D. A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging. J Nucl Med 2005, 46:1980-9.
16. Le Bars D, Lemaire C, Ginovart N, Plenevaux A, Aerts J, Brihaye C, Hassoun W, Leviel V, Mekhsian P, Weissmann D, Pujol JF, Luxen A, Comar D. High-yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY-100635. Nucl Med Biol 1998, 25:343-50. 10.1016/S0969-8051(97)00229-1, 9639295.
17. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 2007, 27:1533-9. 10.1038/sj.jcbfm.9600493, 17519979.
18. Gunn RN, Sargent PA, Bench CJ, Rabiner EA, Osman S, Pike VW, Hume SP, Grasby PM, Lammertsma AA. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage 1998, 8:426-40. 10.1006/nimg.1998.0379, 9811559.
19. Costes N, Merlet I, Zimmer L, Lavenne F, Cinotti L, Delforge J, Luxen A, Pujol JF, Le Bars D. Modeling [18F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection. J Cereb Blood Flow Metab 2002, 22:753-65. 10.1097/00004647-200206000-00014, 12045674.
20. Parsey RV, Arango V, Olvet DM, Oquendo MA, Van Heertum RL, John Mann J. Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography. J Cereb Blood Flow Metab 2005, 25:785-93. 10.1038/sj.jcbfm.9600072, 15716853.
21. Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, Woods R, Paus T, Simpson G, Pike B, Holmes C, Collins L, Thompson P, MacDonald D, Iacoboni M, Schormann T, Amunts K, Palomero-Gallagher N, Geyer S, Parsons L, Narr K, Kabani N, Le Goualher G, Boomsma D, Cannon T, Kawashima R, Mazoyer B. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci 2001, 356:1293-322. 10.1098/rstb.2001.0915, 1088516, 11545704.
22. Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ. Comparing functional (PET) images: the assessment of significant changes. J Cereb Blood Flow Metab 1991, 11:690-9.
23. Friston KJ, Holmes AP, Worsley KJ, Poline JB, Frith CD, Frackowiak RJS. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995, 3:189-210.
24. Vergé D, Daval G, Marcinkiewicz M, Patey A, el Mestikawy S, Gozlan H, Hamon M. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci 1986, 6:3474-82.
25. Pranzatelli MR, Durkin MM, Barkai AI. Quantitative autoradiography of 5-hydroxytryptamine1A binding sites in rats with chronic neonatal 5,7-dihydroxytryptamine lesions. Brain Res Dev Brain Res 1994, 80:1-6. 10.1016/0165-3806(94)90082-5, 7955334.
26. Huggenvik JI, Michelson RJ, Collard MW, Ziemba AJ, Gurley P, Mowen KA. Characterization of a nuclear deformed epidermal autoregulatory factor-1 (DEAF-1)-related (NUDR) transcriptional regulator protein. Mol Endocrinol 1998, 12:1619-39. 10.1210/me.12.10.1619, 9773984.
27. Bottomley MJ, Collard MW, Huggenvik JI, Liu Z, Gibson TJ, Sattler M. The SAND domain structure defines a novel DNA-binding fold in transcriptional regulation. Nat Struct Biol 2001, 8:626-33. 10.1038/89675, 11427895.
28. Mickey BJ, Ducci F, Hodgkinson CA, Langenecker SA, Goldman D, Zubieta JK. Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo. J Neurosci 2008, 28:11354-9. 10.1523/JNEUROSCI.2391-08.2008, 2613649, 18971477.
29. Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry 2007, 62:847-55. 10.1016/j.biopsych.2007.03.001, 2711771, 17544382.
30. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, Blier P, Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 1997, 94:5308-13. 10.1073/pnas.94.10.5308, 24674, 9144233.
31. Weiss LA, Abney M, Cook EH, Ober C. Sex-specific genetic architecture of whole blood serotonin levels. Am J Hum Genet 2005, 76:33-41. 10.1086/426697, 1196431, 15526234.
32. Cidis Meltzer C, Drevets WC, Price JC, Mathis CA, Lopresti B, Greer PJ, Villemagne VL, Holt D, Mason NS, Houck PR, Reynolds CF, DeKosky ST. Gender-specific aging effects on the serotonin 1A receptor. Brain Res 2001, 895:9-17. 10.1016/S0006-8993(00)03211-X, 11259754.
33. Tauscher J, Verhoeff NP, Christensen BK, Hussey D, Meyer JH, Kecojevic A, Javanmard M, Kasper S, Kapur S. Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET. Neuropsychopharmacology 2001, 24:522-30. 10.1016/S0893-133X(00)00227-X, 11282252.
34. Møller M, Jakobsen S, Gjedde A. Parametric and regional maps of free serotonin 5HT1A receptor sites in human brain as function of age in healthy humans. Neuropsychopharmacology 2007, 32:1707-14. 10.1038/sj.npp.1301310, 17251909.
35. Gozlan H, Thibault S, Laporte AM, Lima L, Hamon M. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes. Eur J Pharmacol 1995, 288:173-86. 10.1016/0922-4106(95)90192-2, 7720779.
36. Millet P, Moulin M, Bartoli A, Del Guerra A, Ginovart N, Lemoucheux L, Buono S, Fagret D, Charnay Y, Ibáñez V. In vivo quantification of 5-HT1A-[18F]MPPF interactions in rats using the YAP-(S)PET scanner and a beta-microprobe. Neuroimage 2008, 41:823-34. 10.1016/j.neuroimage.2008.02.062, 18436452.